Evaluation of the Cost of Treating Cirrhosis in Patients Hospitalised in the Hepatology and Gastroenterology Department of the Sourô Sanou University Hospital Center
- 1 Higher Institute of Health Sciences, University Nazi Boni, Bobo-Dioulasso, Burkina Faso
- 2 Higher Institute of Health Sciences, University Nazi Boni, Bobo-Dioulasso, Burkina Faso
- 3 Sourô Sanou University Hospital Centre, Bobo-Dioulasso, Burkina Faso
- 4 Sourô Sanou University Hospital Centre, Bobo-Dioulasso, Burkina Faso
- 5 Higher Institute of Health Sciences, University Nazi Boni, Bobo-Dioulasso, Burkina Faso
- 6 Sourô Sanou University Hospital Centre, Bobo-Dioulasso, Burkina Faso
- 7 Health Sciences Training and Research Unit, University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso
Abstract
Introduction : Liver cirrhosis is the final stage of many chronic liver diseases and remains a major cause of morbidity and mortality. In Burkina Faso, it is the most prevalent liver disease, but its medical and economic implications have been little explored. The aim of this study was to assess the costs of hospital care for cirrhosis at the Sourô Sanou University Hospital Centre (CHUSS) in Bobo-Dioulasso. Methods : An observational, cross-sectional, descriptive study was conducted from 1 March to 1 May 2025. It involved 50 cirrhotic patients hospitalised in the Hepatology and Gastroenterology Department who met the inclusion criteria and agreed to participate. Sociodemographic, clinical and economic variables were collected and analysed. Results : The average age of patients was 50.8 years, with a sex ratio of 5.25. Fifty-four per cent of patients were farmers, most of whom lived in rural areas. Two had health insurance. Self-funding and family support were the two primary financing sources: half paid for their own care and 44% of the funding came from parents. The median monthly income was 83.300 CFA francs (139 USD). The average length of hospital stay was 5.4 ± 1.7 days. The average direct medical cost was 168,710 CFA francs (281 USD), dominated by paraclinical examinations (108,588 CFA francs or 181 USD), followed by treatment (53,780 CFA francs or 90 USD) and hospitalisation (5600 CFA francs or 9.3 USD). The average direct non-medical cost was estimated at 18,886 CFA francs (31.5 USD). In cases of hepatic encephalopathy, the cost peaked at 196,352 CFA francs (327.25 USD). Indirect costs, assessed in 16 patients, averaged 12,153 CFA francs (20.25 USD). Conclusion : Hospital care for cirrhosis at the CHUSS represents a considerable economic burden for patients and their families, in a context marked by the absence of universal health coverage.
- Balian, A. (2005) La cirrhose et ses complications. Doin, 171 p.
- Tham, E.K.J., Tan, D.J.H., Danpanichkul, P., Ng, C.H., Syn, N., Koh, B., et al . (2025) The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. Liver International , 45, 478-493. https://doi.org/10.1111/liv.70001
- Somé, E.N., Nana, F.W., Lompo, I.T., Maxime, D. and Sombié, R. (2021) Cirrhosis: Therapeutic Aspects and Outcome for Hospitalized Patients in Burkina Faso. Open Journal of Epidemiology , 11, 152-162. https://doi.org/10.4236/ojepi.2021.112014
- Institute for Health Metrics and Evaluation (IHME) (2024) IHME GBD 2021 Data Tools Guide. IHME, 26 p.
- Nguyen, D., Nguyen, T. and Pho, N. (2017) Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015. Value in Health , 20, A633. https://doi.org/10.1016/j.jval.2017.08.1429
- Kanwal, F., Nelson, R., Liu, Y., Kramer, J.R., Hernaez, R., Cholankeril, G., et al . (2023) Cost of Care for Patients with Cirrhosis. American Journal of Gastroenterology , 119, 497-504. https://doi.org/10.14309/ajg.0000000000002472
- Lévy, P. and Le Pen, C. (2018) L’évaluation médico-économique: Concepts et méthodes. Le Grand Métier, 172 p.
- Hamidine, I. and Al, E. (2024) Aspects épidémiologiques et pronostiques de la cirrhose décompensée à l’Hôpital National de Zinder. Revue Malienne d ’ Infectiologie et de Microbiologie , 19, 34-39. https://doi.org/10.53597/remim.v19i3.2889
- Doffou, A.S., Bangoura, A.D., Kouamé, G.D., Yaogo, A., Méité, M., Kissi, H., et al . (2019) La cirrhose alcoolique chez le noir africain au centre hospitalier universitaire de Yopougon: Caractéristiques épidémiologiques, cliniques et biologiques. Revue Internationale des Sciences Médicales d ’ Abidjan , 21, 212-218.
- Sawadogo, W.A. (2012) Aspects épidémiologiques, cliniques, paracliniques, étiologiques et évolutifs de la cirrhose du foie au Centre Hospitalier Universitaire Sourô Sanou de Bobo Dioulasso: À propos de 87 cas. Thèse, Université de Ouagadougou, UFR/SDS, Thèse No. 117, 150 p.
- Diarra, M., Konaté, A., Soukho, A., Dicko, M., Kallé, A., Doumbia, K., et al . (2010) Aspects évolutifs de la maladie cirrhotique dans un service d’hépato-gastroentérologie au Mali. Mali Médical , 25, 42a.
- Bellil, L. and Bendjazia, F.L. (2020) Étude épidémiologique, descriptive et analytique de la cirrhose hépatique. [Mémoire]. Université des Frères Mentouri Constantine 1, Faculté des Sciences de la Nature et de la Vie, Département de Biologie Animale, 60 p.